Copyright
©The Author(s) 2021.
World J Clin Cases. Jan 6, 2021; 9(1): 8-23
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.8
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.8
Table 2 Summary of potential treatment agents and mechanisms of action for coronavirus disease-2019 infections
Potential treatment agents | Mechanism of action |
Corticosteroid | Anti-inflammatory effect |
Remdesivirand ribavirin | Inhibition of the RNA-dependent RNA polymerase |
Interferon therapy | Inhibition of viral entry, transcription, replication, translation, assembly |
Proteaseinhibitors (lopinavir/ritonavir) | Inhibition of papain-like protease and 3C-like protease |
Hydroxychloroquine and chloroquine | Inhibition of endosomal acidification and negatively influences virus–receptor binding, as well as interfere with the glycosylation of cellular receptors of SARS-CoV |
Oseltamivir | Neuraminidase inhibitor |
Tocilizumab | A recombinant monoclonal antibody that competitively inhibits the binding of IL-6 to its receptor. |
Convalescent plasma | Neutralizing the SARS-CoV-2 antibodies |
- Citation: Krishnan A, Hamilton JP, Alqahtani SA, Woreta TA. COVID-19: An overview and a clinical update. World J Clin Cases 2021; 9(1): 8-23
- URL: https://www.wjgnet.com/2307-8960/full/v9/i1/8.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i1.8